ESPR
Esperion Therapeutics Inc
NASDAQ: ESPR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.00
+4.71% today
Updated 2026-04-30
Market cap
$491.64M
P/E ratio
—
P/S ratio
1.22x
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$1 – $4
Volume
6.1M
Esperion Therapeutics Inc (ESPR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |